focus -WSS

focus

author：entertainment 2025-10-01 10:59:36 - browse：98

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The release of Novo Nordisk’s latest earnings report on Thursday provided a chance for executives to tout their major win this week — outcomes from a large trial showing the company’s obesity drug Wegovy cut the risk of heart complications by 20%.

But once again, much of the attention was focused on the company’s struggles to meet what Novo CEO Lars Fruergaard Jørgensen referred to as the “overwhelming demand for Wegovy.”

Jørgensen reiterated that the company was racing to expand supply and had brought on more contract manufacturing support, but Novo said Thursday that the company would continue to restrict the availability of lower-strength starter doses in the United States to ensure that patients on the drug would not have their medication interrupted.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Brazil's Jair Bolsonaro is barred from running for office until 2030

WSS

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Medical experts exlpore how to eliminate bias in clinical algorithms

The high cost of giving birth even with insurance

GOP inquiry over gain

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

How one medical school became remarkably diverse

focus

focus

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

UnitedHealth wins $3.3 billion takeover of Amedisys

Apple is now the first public company to be valued at $3 trillion

The high cost of giving birth even with insurance

Activists slam private health insurers over coverage restrictions

After affirmative action ruling, medical educators look to 'holistic review'

Apple is now the first public company to be valued at $3 trillion

Tuskegee Airman Raymond Cassagnol dies at 102

Psychedelics group wrestles with new pharma identity

What does generative AI mean for health care? We asked experts

hotspot

Walensky prepares to leave CDC — and Congress — behind

ADA: All diabetes patients should be screened for liver condition

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

The simple reason for the increase in autism diagnosis

Virginia high school admissions case could be legal follow

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

Wikipedia

knowledge

entertainment

hotspot